Episode Details

QuidelOrtho is eyeing a private equity sale of its COVID-19 test division to tackle its $3.8 billion debt load, a move analysts see as potentially transformative — and it’s already sending the stock soaring after weekend news broke. The market’s reaction has been strong, especially given the stock’s turbulent year, while CEO stock purchases signal leadership confidence in the company’s turnaround potential. Still, the shares remain down 35% year-to-date and trading far below their earlier highs.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/4d3cddcc0f2174de